ALX Oncology Holdings Inc.ALX Oncology Holdings Inc.ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc.

No trades
See on Supercharts

ALXO fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia in March 2015 and is headquartered in South San Francisco, CA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
ALXO has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company